IP Library Granted Patent US 12,444,048
Granted Patent B2
US 12,444,048 · App. 18/321,110 · Granted Oct 14, 2025

Diagnosis assistant apparatus, diagnosis assistant method, and non-transitory computer readable medium

Inventors: Kohei Watanabe (Utsunomiya, JP); Atsuko Sugiyama (Nasushiobara, JP)
Assignee: CANON MEDICAL SYSTEMS CORPORATION
G06T7/0012G16H50/30G06T2207/30068G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,444,048
App. No.
18/321,110
Granted
Oct 14, 2025
Kind
B2
Abstract

A diagnosis assistant apparatus according to an embodiment includes a processor. The processor acquires a first measured value of a biomarker in a first liquid sample that is collected from a subject before a physical stimulus is applied and a second measured value of the biomarker in a second liquid sample that is collected from the subject after the physical stimulus is applied. The processor performs a determination on at least one of presence/absence and a property of a lesion based on the first measured value and the second measured value.

Claims (40)

1. A diagnosis assistant apparatus, comprising: a processor configured to:

acquire a first measured value of a biomarker in a first liquid sample that is collected from a subject before a physical stimulus is applied and a second measured value of the biomarker in a second liquid sample that is collected from the subject after the physical stimulus is applied; and

perform a determination on at least one of a presence/absence and a property of a lesion based on the first measured value and the second measured value.

2. The diagnosis assistant apparatus according to claim 1 , wherein the processor calculates an index of determination indicating at least one of an amount and a ratio by which the second measured value increases from the first measured value, and the processor performs the determination based on the calculated index of determination.

3. The diagnosis assistant apparatus according to claim 2 , wherein the processor changes a determination condition for the determination when the index of determination is greater than a predetermined threshold.

4. The diagnosis assistant apparatus according to claim 2 , wherein

the processor acquires information about an intensity of the physical stimulus, and

the processor calculates the index of determination when the intensity of the physical stimulus is greater than a predetermined threshold.

5. The diagnosis assistant apparatus according to claim 1 , wherein the physical stimulus is a compression to a breast for mammography imaging.

6. The diagnosis assistant apparatus according to claim 1 , wherein the physical stimulus is an ultrasonic irradiation to the subject.

7. The diagnosis assistant apparatus according to claim 1 , wherein the processor

performs a detection of at least one of the presence/absence and the property of the lesion based on a medical image that is obtained from imaging the subject,

further acquires the medical image, and

performs the determination further based on a result of the detection.

8. The diagnosis assistant apparatus according to claim 7 , wherein the processor calculates an index of determination indicating at least one of an amount or a ratio by which the second measured value increases from the first measured value, and changes a detection condition for the detection when the index of determination is greater than a predetermined threshold.

9. The diagnosis assistant apparatus according to claim 8 , wherein the changing the detection condition includes changing a detection algorithm for detecting at least one of the presence/absence and the property of a lesion from the medical image to a detection algorithm corresponding to a type of a biomarker increased after the physical stimulus.

10. The diagnosis assistant apparatus according to claim 1 , wherein the lesion includes breast cancer, liver cancer, kidney cancer, prostate cancer, hepatic cancer, pancreas cancer, bladder cancer, bowel cancer, stomach cancer, esophageal cancer, uterus cancer, skin cancer, or lung cancer.

11. The diagnosis assistant apparatus according to claim 2 , wherein

the determination includes

a first determination in which the lesion is determined to be present when the first measured value or the second measured value is greater than a first predetermined threshold, and

a second determination in which the lesion is determined to be present when the index of determination is greater than a second predetermined threshold, and

when the lesion is not determined to be present in the first determination, the processor calculates the index of determination and performs the second determination based on the index of determination.

12. The diagnosis assistant apparatus according to claim 2 , wherein

the determination includes

a first determination in which the lesion is determined to be present when the first measured value or the second measured value is greater than a first predetermined threshold, and

a second determination in which a malignancy grading is determined to be high as the property of the lesion when the index of determination is greater than a second predetermined threshold, and

when the lesion is not determined to be present in the first determination, the processor calculates the index of determination and performs the second determination based on the index of determination.

13. The diagnosis assistant apparatus according to claim 2 , wherein

the determination includes a first determination in which the lesion is determined to be present when the first measured value is greater than a predetermined threshold, and

when the lesion is not determined to be present in the first determination, the processor

acquires the second measured value, and

calculates the index of determination and performs a second determination on at least one of the presence/absence and the property of the lesion based on the calculated index of determination.

14. A diagnosis method comprising:

collecting a first liquid sample from a subject before a physical stimulus is applied;

collecting a second liquid sample from the subject after the physical stimulus is applied;

acquiring a first measured value of a biomarker in the first liquid sample and a second measured value of the biomarker in the second liquid sample; and

performing a determination on at least one of a presence/absence and a property of a lesion based on the first measured value and the second measured value.

15. A non-transitory computer readable medium readable by a computer, the medium storing a program that, when executed by a computer, causes the computer to perform:

acquiring a first measured value of a biomarker in a first liquid sample that is collected from a subject before a physical stimulus is applied and a second measured value of the biomarker in a second liquid sample that is collected from the subject after the physical stimulus is applied; and

performing a determination on at least one of a presence/absence and a property of a lesion based on the first measured value and the second measured value.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2023
From: WATANABE, KOHEI; SUGIYAMA, ATSUKO
To: CANON MEDICAL SYSTEMS CORPORATION
Reel/Frame 063713/0720 →
Priority Claims (1)
JP 2022-086128 · May 26, 2022 · national
Continuity (1)
Related Publication 20230386027A1 · Nov 30, 2023
References Cited (7)
US 11994522B2 · Wang · 2024 [cited by examiner]
US 20200041492A1 · Demaria · 2020 [cited by applicant]
JP 2020511674A · 2020 [cited by applicant]
Bosch et al, “Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population”, 2019, Am J Gastroenterol 2019;114: pp. 1909-1918 (Year: 2019). [cited by examiner]
Whitehouse et al, “Blood Biomarkers and Structural Imaging Correlations Post-Traumatic Brain Injury: A Systematic Review”, 2021, Neurosurgery vol. 90, issue 2, pp. 170-179 (Year: 2021). [cited by examiner]
Perez, A. et al “The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines” Annals of Oncology, vol. 28, Supplement 6, (2017), 2 Pages. [cited by applicant]
Förnvik, D. et al. “Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment” Breast Cance… [cited by applicant]